Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy

NCT03418844 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT03418844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03418844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
Lead sponsor
Centre Francois Baclesse
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 7, 2018
Completion date
December 31, 2025
Enrollment
268 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

germ cell tumor, malignant non-epithelial ovarian tumors, sex cord stromal tumor